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Abstract. The present study was conducted to investigate the possible protective effects of lycopene (LC) and ellagic
acid (EA) on cyclophosphamide (CP)-induced testicular and spermatozoal toxicity associated with the oxidative stress and
apoptosis in male rats. Forty-eight healthy adult male Sprague-Dawley rats were divided into six groups of eight rats each.
The control group was treated with placebo; the LC, EA and CP groups were given LC (10 mg kg−1), EA (2 mg kg−1)
and CP (15 mg kg−1), respectively, alone; the CP+LC group was treated with a combination of CP (15 mg kg−1) and
LC (10 mg kg−1); and the CP+EA group was treated with a combination of CP (15 mg kg−1) and EA (2 mg kg−1). All
treatments were maintained for 8 weeks. At the end of the treatment period, bodyweight and the weight of the reproductive
organs, sperm concentration and motility, testicular tissue lipid peroxidation, anti-oxidant enzyme activity and apoptosis
(i.e. Bax and Bcl-2 proteins) were determined. Administration of CP resulted in significant decreases in epididymal sperm
concentration and motility and significant increases in malondialdehyde levels. Although CP significantly increased the
number of Bax-positive (apoptotic) cells, it had no effect on the number of Bcl-2-positive (anti-apoptotic) cells compared
with the control group. However, combined treatment of rats with LC or EA in addition to CP prevented the development
of CP-induced lipid peroxidation and sperm and testicular damage. In conclusion, CP-induced lipid peroxidation leads to
structural and functional damage, as well as apoptosis, in spermatogenic cells of rats. Both LC and EA protect against the
development of these detrimental effects.
Additional keyword: sperm characteristics.
Introduction
Cyclophosphamide (CP), a cytotoxic alkylating agent, has anti-
cancer and immunosuppressive effects for organ transplantation
and autoimmune diseases (Dollery 1999). Despite its thera-
peutic importance, a wide range of adverse effects, including
reproductive toxicity, have been reported for the drug. Sper-
matogenic cells are a particular target for the damaging effects
of CP because it targets fast-dividing cells, changing the compo-
sition of the sperm nuclear matrix (Codrington et al. 2007) and
inducing DNA cross-links, DNA double-strand breaks (Aguilar-
Mahecha et al. 2005) and germ cell apoptosis (Cai et al. 1997;
He et al. 2006). Decreased reproductive organ weights, oligo-,
azoo- and teratozoospermia, low levels of testosterone and LH,
atrophied seminiferous tubules, degenerated spermatogenic cells
and apoptosis are some of the detrimental effects induced by
CP (Elangovan et al. 2006; Selvakumar et al. 2006; Chamorro-
Cevallos et al. 2008; Tripathi and Jena 2008; İlbey et al. 2009).
The precise mechanism by which CP causes testicular and other
organ toxicity is not fully known; however, numerous studies
have shown that exposure to CP can disrupt the redox balance
of tissues, suggesting that biochemical and physiological dis-
turbances may result from oxidative stress (Selvakumar et al.
2005a, 2005b; Ahmadi et al. 2008). Free radicals are normally
generated in subcellular compartments of the testis, particularly
mitochondria, which are subsequently scavenged by anti-oxidant
defence systems of the corresponding cellular compartments
(Agarwal et al. 2008a). However, this balance can easily be
broken by chemicals such as CP, which disrupt the pro-oxidant–
anti-oxidant balance, leading to cellular dysfunction (Howell
and Shalet 2005). In addition, the mitochondrial membrane of
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spermatozoa is more susceptible to lipid peroxidation, because
this compartment is rich in polyunsaturated fatty acids and has
been shown to contain low amounts of anti-oxidants (Aitken and
McLaughlin 2007; Agarwal et al. 2008c).
Recently, there has been increased interest in understanding
the roles and mechanisms of the carotenoids and phytochemi-
cals as inhibitors of oxidative stress. Lycopene (LC), a carotenoid
occurring naturally in tomatoes, has attracted considerable atten-
tion as an anti-oxidant. Of the various defence strategies, LC is
most likely involved in the scavenging of two of the reactive oxy-
gen species (ROS), singlet molecular oxygen (1O2) and peroxyl
radicals. It has been reported that LC efficiently scavenges per-
oxyl radicals, especially at low oxygen tension, and contributes
to the defence against lipid peroxidation (Stahl and Sies 2003).
Of all the phytochemicals, ellagic acid (EA) has received the
most attention because of its wide array of biological proper-
ties, including radical scavenging, chemoprevention (Ateşşahin
et al. 2007; Yüce et al. 2007; Türk et al. 2008), anti-atherogenic
and anti-apoptotic (Yu et al. 2005) actions and oestrogen recep-
tor modulation (Papoutsi et al. 2005). EA contains four hydroxyl
groups and two lactone groups, with the hydroxyl groups known
to increase anti-oxidant activity in lipid peroxidation and to pro-
tect cells from oxidative damage (Pari and Sivasankari 2008). In
the light of this information, the present study was designed to
investigate whether LC or EA have a possible protective effect in
rats against CP-induced changes in the characteristics of epididy-




CP (500 mg; Endoxan) was purchased from Eczacıbaşı-Baxter
(İstanbul, Turkey); LC 10% FS (Redivivo; code 7803) was
obtained from DSM Nutritional Products (İstanbul, Turkey);
and EA was obtained from Fluka (Steinheim, Germany). All
other chemicals were purchased from Sigma-Aldrich Chemical
(St Louis, MO, USA).
Animals and experimental design
Forty-eight healthy adult male Sprague-Dawley rats (8 weeks
old) were used. The rats were obtained from Fırat Univer-
sity Experimental Research Centre (Elazığ, Turkey) and were
housed under standard laboratory conditions (24 ± 3◦C, 40–
60% humidity, 12-h light–dark cycle). A commercial pellet diet
(Elazığ Food Co., Elazığ, Turkey) and fresh drinking water were
available ad libitum. The protocol for animal use was approved
by the Institutional Review Board of the National Institute of
Health and Local Committee on Animal Research.
Rats were randomly divided into six experimental groups of
eight rats as follows: (1) a control group, given 0.5 mL slightly
alkaline solution + 0.5 mL corn oil every other day; (2) the LC
group, given 0.5 mL slightly alkaline solution + 0.5 mL of a
10 mg kg−1 LC solution every other day; (3) the EA group,
given 0.5 mL corn oil + 0.5 mL of a 2 mg kg−1 EA solution every
other day; (4) the CP group, given 0.5 mL of 15 mg kg−1 CP + a
mixture of slightly alkaline solution and corn oil (0.5 mL) once
a week; (5) the CP+LC group, given 0.5 mL of 15 mg kg−1
CP once a week + 0.5 mL of a 10 mg kg−1 LC solution every
other day; and (6) the CP+EA group, given 0.5 mL of
15 mg kg−1 CP once a week + 0.5 mL of a 2 mg kg−1 EA solu-
tion every other day. The LC was suspended in corn oil, whereas
EA, which is difficult to dissolve, was suspended in alkaline
solution (0.01 M NaOH, ∼pH 12). The pH of the final solu-
tion administered to rats was ≈8. The doses of LC and EA
used in the present study were based on those used in earlier
studies (Türk et al. 2007, 2008). However, because the dura-
tion of the treatment period in the present study was longer
than that in the previous studies, the doses of the anti-oxidants
used were decreased. All treatments were applied by gavage.
Because the spermatogenic cycle, including spermatocytogene-
sis, meiosis and spermiogenesis, in rats is 48–52 days (Bennett
and Vickery 1970), the treatment period in the present study was
set at 8 weeks.
Sample collection and homogenate preparation
Rats were killed under light ether anaesthesia at the end of
8 weeks. The testes, epididymides, seminal vesicles and ventral
prostate were removed, cleared of adhering connective tissue and
weighed. Blood samples were collected and centrifuged at 3000g
for 10 min to obtain plasma. One of the testicles was fixed in
10% neutral formalin solution for immunohistochemical exam-
ination. The other testicle and plasma samples were stored at
−20◦C until used for biochemical analyses. Testis tissues were
taken from the deep-freezer and weighed. They were then trans-
ferred to cold glass tubes and diluted with a ninefold volume of
phosphate buffer (pH 7.4). For the enzymatic analyses, testicular
tissues were minced and then homogenised used a Teflon–glass




The epididymal sperm concentration was determined using
a haemocytometer according to the method of Türk et al. (2007,
2008) with some modifications. The cauda of the right epi-
didymis was finely minced using anatomical scissors in 1 mL
isotonic saline in a Petri dish. The tissue was then squashed
using tweezers for 2 min and allowed to set at room temperature
for 4 h to enable the migration of all spermatozoa from the epi-
didymal tissue into the fluid. After incubation, the epididymal
tissue–fluid mixture was filtered through a 3-µ mesh to separate
the supernatant from the tissue. The supernatant, containing all
the epididymal spermatozoa, was drawn into a pipette designed
for counting red blood cells up to the 0.5 mark. A solution con-
taining 0.595 M sodium bicarbonate, 1% formalin and 0.025%
eosin was then drawn up into the pipette up to 101 mark. This
resulted in a dilution rate of 1 : 200. The contents of the pipette
were mixed by holding the ends of the pipette between the thumb
and index finger and shaking the pipette vigorously for 100 back-
and-forth (30 cm) movements.The bulb of the pipette contained a
small glass bead that made thorough mixing possible. After mix-
ing, sufficient solution was expelled from the pipette to ensure
that diluents containing no spermatozoa were flushed from the
capillary. Approximately 10 µL diluted sperm suspension was
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transferred to both counting chambers of an improved Neubauer
(Deep 1/10 mm; LABART, Darmstadt, Germany) and allowed to
stand for 5 min.The spermatozoa in both chambers were counted
under a light microscope at ×200 magnification.
Sperm motility
The percentage of motile spermatozoa was determined using
a light microscope with a heated stage as described by Sönmez
et al. (2005). To this end, a slide was placed on the heated stage
(37◦C) of a light microscope, 100 µL of Tris buffer solution
(0.3 M Tris (hydroxymethyl) aminomethane, 0.027 M glucose,
0.1 M citric acid) were placed on the slide, followed by the addi-
tion of 10 µL of fluid obtained from the left cauda epididymis
and the solutions mixed using a coverslip. The percentage of
motile spermatozoa was determined visually under the micro-
scope at ×400. Motility estimates were obtained from three
different fields in each sample.The mean of these three estimates
was used as the final motility score.
Biochemical analyses
Lipid peroxidation
Testicular tissue lipid peroxidation levels were determined
as thiobarbituric acid-reactive substances (TBARS; Placer et al.
1966). The amount of malondialdehyde (MDA) produced was
used as an index of lipid peroxidation. Briefly, one volume
of test sample and two volumes of stock reagent (15% w/v
trichloroacetic acid (TCA) in 0.25 M HCl and 0.375%, w/v thio-
barbituric acid in 0.25 M HCl) were mixed in a centrifuge tube.
The solution was heated in boiling water for 15 min. After cool-
ing, the precipitate was removed by centrifugation at 1500g for
10 min and the absorbance of the supernatant was read on a spec-
trophotometer at 532 nm against a blank containing all reagents
except the test sample (2R/UV-visible; Shimadzu,Tokyo, Japan).
The concentration of MDA is expressed as µM.
Glutathione
Reduced glutathione (GSH) levels in testicular tissue were
determined at 412 nm using the method described by Sedlak
and Lindsay (1968). Briefly, samples were precipitated with
50% TCA and then centrifuged at 1000g for 5 min. The reac-
tion mixture contained 0.5 mL supernatant, 2.0 mL Tris–EDTA
buffer (0.2 M, pH 8.9) and 0.1 mL of 0.01 M 5,5′-dithio-bis-
2-nitrobenzoic acid. The solution was kept at room temper-
ature for 5 min before absorbance was read at 412 nm in a
spectrophotometer. Concentrations of GSH are given in µM.
Glutathione peroxidase activity and protein
concentration
Glutathione peroxidase (GPx) activity in testicular tissue was
determined according to the method of Lawrence and Burk
(1976). The reaction mixture consisted of 50 mM potassium
phosphate buffer (pH 7.0), 1 mM EDTA, 1 mM NaN3, 0.2 mM
NADPH, 1 IU mL−1 oxidised glutathione (GSSG) reductase,
1 mM GSH and 0.25 mM H2O2. An enzyme source (0.1 mL)
was added to 0.8 mL of this solution and the mixture was incu-
bated at 25◦C for 5 min before initiation of the reaction with the
addition of 0.1 mL peroxide solution. Absorbance was recorded
at 340 nm for 5 min on a spectrophotometer. GPx activity was
calculated from the slope of the lines as µmol NADPH oxi-
dised per min. Activity in the blank, in which the enzyme had
been replaced with distilled water, was subtracted from each
sample value. Protein concentrations were determined using the
method of Lowry et al. (1951). GPx activity is expressed as
IU g−1 protein.
Catalase
Testicular catalase activity was determined by measuring the
decomposition of H2O2 at 240 nm, according to the method
described by Aebi (1983). Catalase activity is expressed as
kU g−1 protein, where k is the first-order rate constant.
Superoxide dismutase
Testicular superoxide dismutase (SOD) activity was deter-
mined using xanthine and xanthine oxidase to generate super-
oxide radicals that react with nitroblue tetrazolium (NBT; Flohe
and Otting 1984). Briefly, each sample was diluted 1 : 10 with
phosphate buffer (50 mM, pH 7.5). The assay solution, contain-
ing sodium carbonate buffer (50 mM, pH 10), 0.1 mM xanthine,
0.025 mM NBT, 0.1 mM EDTA, xanthine oxidase (0.1 U mL−1
in 2 M ammonium sulfate) and sample, was mixed in a cuvette.
One unit of SOD activity was defined as the amount of enzyme
required to inhibit NBT by 50%. SOD activity was determined
spectrophotometrically at 560 nm as the degree of inhibition and
is expressed as U mL−1.
Testosterone
Plasma testosterone concentrations were measured by ELISA
(ELISA EIA-1559, 96 Wells kit; DRG Instruments, Marburg,
Germany) according to the manufacturer’s instruction. Concen-
trations are reported as ng dL−1.
Apoptotic and anti-apoptotic cell rates determined
by immunohistochemistry
The avidin–biotin–peroxidase method was used for immuno-
histochemical analyses (Jahnukainen et al. 2004). Testes tissues,
which were embedded in paraffin and sectioned at 4 µm, were
deparaffinised with xylene and dehydrated with an alcohol
series. Testicular sections were incubated in 0.01 M Na-citrate
for 20 min to bring out the antigenic receptors. Sections were
washed with phosphate-buffered saline (PBS) and were then
incubated in 3% H2O2, prepared in PBS, for 10 min to inacti-
vate endogenous peroxidase activity. Non-specific binding was
blocked by incubation of samples with 1% untreated goat serum
for 1 h. Testicular tissues were then incubated with primary rab-
bit polyclonal antibodies directed against Bax (a pro-apoptotic
protein) and Bcl-2 (an anti-apoptotic protein) at dilutions of
1 : 200 and 1 : 400, respectively, in PBS containing 0.1% goat
serum at 37◦C for 1 h. Testicular sections were washed again
in PBS and were incubated with biotinylated secondary anti-
bodies, which were diluted 1 : 1000 in PBS containing 0.1%
goat serum (secondary biotinylated goat anti-rabbit IgG) for
30 min. Thereafter, tissues were washed with PBS and were
incubated with avidin-conjugated horseradish peroxidase for 1 h.
3-Amino-9-etilcarbazole (AEC) was used as colour-determining
substrate. The reaction was stopped the moment the colour
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Table 1. Absolute and relative reproductive organ weight
Data are the mean ± s.e.m. Values with different superscript letters within the same column differ significantly (P < 0.05). LC, lycopene; EA, ellagic acid;
CP, cyclophosphamide
Group Absolute weight (mg) Relative weight (mg g−1 bodyweight)
Testis Epididymis Seminal vesicles Ventral prostate Testis Epididymis Seminal vesicles Ventral prostate
Control 1345.0 ± 25.7 454.2 ± 9.5 901.7 ± 32.2 455.0 ± 26.1 4.99 ± 0.33 1.66 ± 0.12 3.42 ± 0.27 1.72 ± 0.14ab
LC 1353.3 ± 119.8 473.7 ± 7.2 918.3 ± 64.7 463.3 ± 11.2 5.10 ± 0.11 1.80 ± 0.07 3.75 ± 0.42 1.74 ± 0.06ab
EA 1348.3 ± 93.3 456.0 ± 6.1 985.0 ± 47.5 483.3 ± 10.2 5.12 ± 0.08 1.73 ± 0.02 3.76 ± 0.23 1.84 ± 0.03a
CP 1290.0 ± 32.3 430.0 ± 16.1 793.3 ± 34.9 420.0 ± 12.1 4.53 ± 0.19 1.52 ± 0.10 2.80 ± 0.18 1.48 ± 0.08b
CP+LC 1323.3 ± 87.4 465.8 ± 6.1 905.0 ± 48.5 429.2 ± 13.1 4.88 ± 0.29 1.73 ± 0.08 3.34 ± 0.35 1.64 ± 0.06ab
CP+EA 1334.2 ± 99.0 432.5 ± 16.8 838.3 ± 55.0 426.7 ± 25.9 4.84 ± 0.20 1.57 ± 0.06 3.01 ± 0.09 1.53 ± 0.05ab
Table 2. Sperm parameters and immunohistochemical scores
Data are the mean ± s.e.m. Values with different superscript letters within the same column differ significantly (P < 0.05). LC, lycopene; EA, ellagic acid;
CP, cyclophosphamide
Group Sperm motility (%) Epididymal sperm concentration Bax-positive cell score Bcl-2-positive cell score
(million/g tissue)
Control 77.77 ± 2.94ab 347.5 ± 11.5a 0.33 ± 0.21a 0.33 ± 0.21a
LC 85.53 ± 1.86b 344.6 ± 9.7ab 0.17 ± 0.17a 0.50 ± 0.22a
EA 82.76 ± 3.15b 351.3 ± 11.5a 0.67 ± 0.21a 0.50 ± 0.22a
CP 51.07 ± 3.72c 288.8 ± 3.1b 2.17 ± 0.41b 0.57 ± 0.17a
CP+LC 79.42 ± 2.35ab 329.9 ± 16.4ab 1.17 ± 0.17c 1.00 ± 0.00b
CP+EA 68.87 ± 4.01a 313.0 ± 21.3ab 1.33 ± 0.21c 1.00 ± 0.00b
change occurred after the addition of AEC to the samples.
Finally, samples were washed with tap water for 2 min after they
had been stained with Mayer’s haematoxylin for 15 s. Stained
tissues were covered with immune-mount (Lab Vision, UK, cat.
Number: TA-060-UG) and then Bax- and Bcl-2-positive sper-
matogenic cells (from spermatogonia to elongated spermatids)
were evaluated under a light microscope and scored accord-
ing to Kandi Coşkun and Çobanoğlu (2005) as follows: 0,
no stained cells; 1, <25% positive-stained cells; 2, 26–50%
positive-stained cells; 3, 51–75% positive-stained cells; and
4, >75% positive-stained cells.
Statistical analysis
All data are presented as the mean ± s.e.m. Data were analysed
using SPSS Version 10.0 (SPSS Inc., Chicago, IL, USA). One-
way analysis of variance (ANOVA) and post hoc Tukey’s HSD
test were used to evaluate differences between groups. P < 0.05
was considered significant.
Results
Bodyweight and reproductive organ weight
There were no significant differences in mean bodyweight at
the end of the 8-week treatment period between the control, LC,
EA, CP, CP+LC and CP+EA groups (275.6 ± 17.2, 263.3 ± 8.4,
263.5 ± 4.8, 287.3 ± 14.0, 273.8 ± 9.6 and 279.0 ± 17.9 g,
respectively). Absolute and relative reproductive organ weights
are given in Table 1. Treatment with LC and EA alone had
no effect on the absolute and relative organ weights compared
with those in the control group. Although there was a tendency
for decreased absolute and relative organ weights following CP
administration, the difference did not reach statistical signifi-
cance compared with the control group. Similarly, although there
was a tendency for LC or EA administration to CP-treated ani-
mals to increase absolute and relative organ weights compared
with CP treatment alone, the differences did not reach statistical
significance.
Sperm concentration and motility
Table 2 lists changes in epididymal sperm characteristics in
response to the various treatments over the 8 weeks. Although
treatment with LC and EA alone had no effect on any of
the parameters evaluated, CP treatment significantly (P < 0.05)
decreased sperm motility and concentration compared with val-
ues in the control group. A significant increase in sperm motility
(P < 0.05) was observed in the CP+LC and CP+EA groups
compared with values for the CP-treated group. Although there
was a tendency for LC or EA administration to CP-treated rats
to bring sperm concentration back towards control values, the
difference did not reach statistical significance compared with
CP treatment alone.
Biochemical parameters
Testicular tissue lipid peroxidation levels, anti-oxidant enzyme
activities and plasma testosterone concentrations are given
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Table 3. Malondialdehyde and reduced glutathione concentrations and glutathione peroxidase, catalase and superoxide dismutase activity in
testicular tissue and plasma testosterone concentrations
Data are the mean ± s.e.m. Values with different superscript letters within the same column differ significantly (P < 0.05). LC, lycopene; EA, ellagic acid;
CP, cyclophosphamide; MDA, malondialdehyde; GSH, reduced glutathione; GPx, glutathione peroxidase; SOD, superoxide dismutase; k, first-order rate
constant
Group MDA (µM) GSH (µM) GPx (IU g−1 protein) Catalase (kU g−1 protein) SOD (U mL−1) Testosterone (ng dL−1)
Control 93.4 ± 12.0ab 6.54 ± 1.15a 10.24 ± 1.04 6.20 ± 0.35a 1.72 ± 0.28 392 ± 65
LC 106.6 ± 8.9bc 10.4 ± 0.6b 8.45 ± 1.10 13.35 ± 0.89c 1.79 ± 0.26 289 ± 66
EA 105.9 ± 15.4bc 8.74 ± 0.67ab 10.24 ± 2.44 6.50 ± 0.32a 1.60 ± 0.29 354 ± 74
CP 131.3 ± 9.9c 7.50 ± 0.76a 5.12 ± 1.15 11.47 ± 0.73bc 1.38 ± 0.17 206 ± 43
CP+LC 83.2 ± 10.6ab 8.53 ± 0.67ab 7.60 ± 1.29 10.9 ± 1.2b 2.24 ± 0.52 146 ± 36
CP+EA 66.4 ± 10.9a 6.80 ± 1.10a 10.01 ± 1.95 10.54 ± 0.68b 1.82 ± 0.23 183 ± 31
in Table 3. Although treatment with CP alone significantly
(P < 0.05) increased MDA levels compared with the control
group, LC and in particular EA administration to CP-treated
rats significantly (P < 0.05) reduced these increased MDA levels
compared with levels in the CP-treated group. Only LC caused
a significant increase in GSH levels compared with the control
group. Although CP treatment alone decreased GPx activity by
50% compared with that in the control group, LC and EA admin-
istration to CP-treated rats increased the CP-induced decrease in
GPx activity (by 48.4% and 95.5%, respectively). Despite this,
there were no significant differences in GPx activity between the
treatment groups. Catalase activity in the LC, CP, CP+LC and
CP+EA groups was significantly (P < 0.05) higher than that in
the control and EA groups. Although CP administration tended
to decrease SOD activity and plasma testosterone concentrations
compared with the control group, the differences did not reach
statistical significance.
Apoptotic and anti-apoptotic cell rates
Immunohistochemical analysis of Bax staining failed to demon-
strate any significant difference between the control (Fig. 1a),
LC (Fig. 1b) and EA (Fig. 1c) groups. However, Bax-positive
cells were observed more frequently in testis sections from CP-
treated rats (Fig. 2a) than in the control group. Intense staining
was observed in almost all the spermatogenic cell types (from
spermatogonia to elongated spermatids) in testis sections from
CP-treated rats. A decrease in this intense staining was observed
in both the CP+LC (Fig. 2b) and CP+EA (Fig. 2c) groups
compared with CP treatment alone. Administration of CP sig-
nificantly (P < 0.05) increased the number of Bax-positive cells
compared with the control group (Table 2), which was reduced
by LC or EA treatment (P < 0.05).
Immunohistochemical analysis of Bcl-2 staining failed to
demonstrate any significant difference between the control
(Fig. 1d), LC (Fig. 1e), EA (Fig. 1f) and CP (Fig. 2d) groups.
However, significant intense staining was seen in almost all
spermatogenic cells in both the CP+LC (Fig. 2e) and CP+EA
(Fig. 2f) groups compared with the other four groups. Thus,
although CP administration itself did not affect the num-
ber of Bcl-2-positive cells compared with the control group
(Table 2), concomitant administration of LC or EA resulted in a
significant (P < 0.05) increase in the number of Bcl-2-positive
anti-apoptotic cells.
Discussion
Treatment with cytotoxic chemotherapy is associated with sig-
nificant gonadal damage. Alkylating agents, such as CP, are
the most common agents implicated in causing this damage.
Reproductive cells and tissues remain stable when the balance
between free radical production and scavenging anti-oxidants
is maintained. Free radicals can attack and inactivate or alter
the biological activity of molecules such as lipids and proteins,
which are essential for cell function (Agarwal et al. 2008a,
2008b). CP causes excessive production of oxygen-derived free
radicals in the testis (İlbey et al. 2009). Although some authors
(Elangovan et al. 2006; Vaisheva et al. 2007; Tripathi and Jena
2008; İlbey et al. 2009) have reported that CP administration
causes significant decreases in bodyweight and reproductive
organ weight, others (Satoh et al. 2002; Fukushima et al. 2005)
have reported no such effect. In the present study, CP did not
change bodyweight or absolute and relative organ weights com-
pared with the control group. Our findings are in agreement with
the results of Satoh et al. (2002) and Fukushima et al. (2005).
The apparent discrepancies reported in the literature may be due
to differences in the doses used, the duration of treatment, the
route of CP administration and the sensitivity of the animals used
in the different studies.
Because the sperm plasma membrane of contains large
quantities of polyunsaturated fatty acids and sperm cytoplasm
contains low concentrations of scavenging enzymes, sperma-
tozoa are particularly susceptible to the damage induced by
excessive ROS (Aitken and McLaughlin 2007; Agarwal et al.
2008c). The increase in free radicals in cells can induce lipid
peroxidation by oxidative breakdown of polyunsaturated fatty
acids in the membranes of these cells. Obviously, peroxida-
tion of sperm lipids destroys the structure of the lipid matrix
in the plasma membranes and it is associated with rapid loss
of intracellular ATP, leading to axonemal damage, decreased
sperm viability and, in extreme cases, even complete inhibi-
tion of spermatogenesis (Türk et al. 2007, 2008). Selvakumar
et al. (2006) and İlbey et al. (2009) have reported that treat-
ment of male rats with CP results in a significant decrease in







Fig. 1. (a–c) Bax- and (d–f) Bcl-2-positive cells in seminiferous tubules from the control group (a, d), the lycopene (LC)-treated group (b, e) and the ellagic
acid (EA)-treated group (c, f). There were eight rats in each group. (Original magnification ×200.)
sperm concentration and motility. In the present study, it was
observed that CP administration resulted in significant decreases
in sperm motility and concentration compared with the control
group. Our findings are in agreement with those previous studies.
The negative changes observed in sperm quality after CP expo-
sure in the present study may be attributed to the peroxidation
of polyunsaturated fatty acids in the plasma membranes of the
spermatozoa, damage to the flagellum, which is important for
sperm motility, direct impairment of spermatogenic cell develop-
ment, impaired maturation or spermiation and damaged to sperm
DNA.
The pro-apoptotic (Bax) and anti-apoptotic (Bcl-2) proteins
exist when apoptosis reached a high point after the onset of cel-
lular stress. The ratio of these molecules has been implicated as a







Fig. 2. (a–c) Bax- and (d–f) Bcl-2-positive cells in seminiferous tubules from rats treated with cyclophosphamide (CP) alone (a, d), with CP+lycopene
(b, e) or with CP+ellagic acid (c, f). There were eight rats in each group. (Original magnification ×200.)
critical determinant of cell fate, such that elevated Bcl-2 favours
extended survival of cells and increased levels of Bax acceler-
ate cell death (Sinha Hikim and Swerdloff 1999). It has been
reported that acute and chronic exposure to chemotherapeutics,
such as CP (Cai et al. 1997; He et al. 2006), cisplatin (Zhang
et al. 2001) and doxorubicin (Hou et al. 2005), results in elevated
apoptotic germ cell rates. In the present study, Bax-positive cells
were observed more frequently in testis sections from CP-treated
rats than in the control group. Intense staining was observed
in almost all spermatogenic cell types (from spermatogonia to
elongated spermatids) in testis sections from CP-treated rats.
In addition, CP administration significantly elevated the Bax-
positive apoptotic cell score compared with the control group.
In terms of Bcl-2-positive staining and Bcl-2-positive cell scores,
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there were no immunohistochemically significant differences
between the control and CP-treated groups. These findings are
in agreement with the reports mentioned above. H2O2, a type
of ROS, induces testicular germ cell apoptosis by extrinsic and
intrinsic mechanisms, as well as through other regulatory path-
ways (Maheshwari et al. 2009). The elevated apoptotic cell
rates after exposure to CP observed in the present study may
be explained by increased ROS and lipid peroxidation levels
in testicular tissue and spermatogenic cells or direct DNA and
chromatin damage in germ cells.
The use of oxygen during normal metabolism produces ROS,
some of which are highly toxic and deleterious to cells and
tissues. The most abundant ROS formed during the course of
cellular metabolism is •O−2 (Halliwell 1991). Dismutation of•O−2 or the direct action of oxidase enzymes gives rise to H2O2.
This molecule is not a free radical itself but, in the presence of
transition metals (e.g. Cu2+, Fe2+), it is rapidly converted via
the Fenton reaction to the hydroxyl radical (•OH). It is widely
accepted that •OH is the most damaging ROS produced by cells
(Halliwell and Gutteridge 1992). It is generally accepted that
increased lipid peroxidation is one of the toxic manifestations
in the testis following CP administration. Treatment with CP
results in elevated MDA levels, a by-product of lipid peroxida-
tion, due to the excessive generation of free radicals (Ghosh et al.
2002; Selvakumar et al. 2005a, 2006; İlbey et al. 2009). In the
present study, treatment with CP alone resulted in a significant
increase in MDA levels in testicular tissue. This can be attributed
to the CP-induced excessive production of free radicals and the
subsequent increase in lipid peroxidation.
Cells have anti-oxidant mechanisms to combat ROS pro-
duction partially or totally. The first enzymatic reaction in the
reduction pathway of oxygen occurs during the dismutation of
two molecules of •O−2 when they are converted to H2O2 and
diatomic oxygen by the enzyme SOD.Two types of enzymes par-
ticipate in the removal of H2O2 from the cellular environment,
namely peroxidases and catalase. The most abundant peroxidase
is GPx. This enzyme uses GSH as a substrate (Matés 2000). It
has been demonstrated that CP reduces GSH levels, as well as
GPx, catalase and SOD activity, in the testis (Ghosh et al. 2002;
Selvakumar et al. 2005a, 2006; İlbey et al. 2009). However,
Salvemini et al. (1999) reported that GSH synthesis may be
induced in cells exposed to oxidative stress as an adaptive pro-
cess. In the same way,Yılmaz et al. (2006) suggested that, under
conditions of oxidative stress, there may be positive regulation of
GSH biosynthesis, resulting in increased levels of GSH. Catalase
activity may increase in cells under oxidative stress to compen-
sate for the lower activity of GSH reductase or NADPH (Pande
and Flora 2002). Although CP administration in the present
study caused a significant increase in catalase activity, it did
not significantly increase GSH levels or decrease GPx and SOD
activity compared with the control group. The non-significant
increase in GSH levels after CP treatment in the present study
may be attributed to the adaptive process of GSH. The signif-
icant increase in catalase activity in testicular tissue induced
by CP may be explained as a compensatory mechanism for the
lower GPx and SOD activity. The non-significant effects of CP
on GPx and SOD activity in the present study may be attributed
to the excessive use of these anti-oxidants to scavenge the free
radicals. The activity of microsomal steroidogenic enzymes (i.e.
3β-hydroxysteroid dehydrogenase (HSD) and 17β-HSD) in the
testis is reduced in the presence of elevated free radical prod-
ucts (MDA) induced by CP (Ghosh et al. 2002). In the present
study, although CP administration tended to decrease plasma
testosterone concentrations, the effect was not statistically sig-
nificant. This may be correlated with the inhibition of testicular
steroidogenesis and impairment of Leydig cells.
It is known that LC is the most effective anti-oxidant among
the carotenoids. It is a highly efficient scavenger of 1O2 and
other excited species. During 1O2 quenching, energy is trans-
ferred from 1O2 to the LC molecule, converting it to the energy
rich triplet state. In contrast, trapping of other ROS, such as
•OH, NO2 or peroxynitrite, leads to oxidative breakdown of the
LC molecule. Thus, LC may protect in vivo against the oxi-
dation of lipids, proteins and DNA (Stahl and Sies 2003). It
has been reported that EA, a naturally occurring plant-derived
polyphenol (Soong and Barlow 2004), exhibits anti-oxidative
properties both in vivo (Yüce et al. 2007; Türk et al. 2008) and
in vitro (Seeram et al. 2005). It also chelates metal ions and
prevents iron- and copper-catalysed formation of ROS. In ear-
lier studies, we found that LC and EA protect the testes and
spermatozoa against cisplatin- and adriamycin-induced toxicity
(Ateşşahin et al. 2006a, 2006b;Türk et al. 2008).Yu et al. (2005)
have reported that EA reduces oxidative stress and apoptosis
in hyperlipidaemic rabbits. In the present study, the adminis-
tration of LC and EA to CP-treated rats resulted in significant
increments in sperm motility, but non-significant increases in
sperm concentration, compared with the CP-treated group. A
decrease in Bax-positive and an increase in Bcl-2-positive stain-
ing in almost all spermatogenic cells was observed in both the
CP+LC and CP+EA groups compared with that in the CP
group. In addition to decreasing the CP-induced increase in Bax-
positive apoptotic cell scores, LC and EA also increased the
anti-apoptotic Bcl-2-positive cell scores. These improvements
in testicular tissue and sperm quality after LC or EA admin-
istration may be explained by the partial or total modulation
of CP-induced immunohistochemical damage, as well as the
tendency for increased sperm concentrations in the epididymis,
decreases in the number of apoptotic cells and lipid peroxidation
and non-significant increases in GPx and SOD activity.
It has been reported that, in the testis, LC and EA decrease
MDA levels and increase GSH levels and GPx and catalase
activity (Ateşşahin et al. 2006a, 2006b; Türk et al. 2008). In
the present study, it was observed that LC and in particu-
lar EA administration to CP-treated rats significantly reduced
the CP-induced increase in MDA levels. The decline in lipid
peroxidation in testicular tissue apparently indicates that LC
and EA potently scavenge free radicals and suppress oxida-
tive DNA damage. Although LC and EA administration to
CP-treated rats increased the CP-induced decrease in GPx
activity (by 48.4% and 95.5%, respectively), these increments
did not reach statistical significance. No significant changes
were observed in catalase activity and GSH and testosterone
concentrations between the CP, CP+LC and CP+EA groups.
That is, LC and EA have no marked effects on the activity
of endogenous anti-oxidant enzymes and plasma testosterone
concentrations.
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In conclusion, the results of the present study suggest that
LC and EA have modulatory effects against testicular and sper-
matozoal toxicity induced by CP. These modulatory effects of
LC and EA seem to involve the suppression of lipid peroxi-
dation and apoptosis. According to the findings of the present
study, although LC and EA have no marked effects on the activ-
ity of endogenous anti-oxidant enzymes, they do have potent
anti-oxidant and anti-apoptotic actions because they inhibit lipid
peroxidation and apoptosis. Therefore, LC or EA may be used in
combination with CP in the treatment of cancer patients, those
with autoimmune diseases and after transplantation to improve
CP-induced damage to sperm quality and to prevent apoptosis
and lipid peroxidation.
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Lycopene protects against cyclosporine A-induced testicular toxicity in
rats.Theriogenology 67, 778–785. doi:10.1016/J.THERIOGENOLOGY.
2006.10.013
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